Partial Volume Effect Corrected Metabolically Active Tumor Volume From Pet For Early-Stage Lung Cancer

e dalah,c yang,k kainz,e gore,r hellman,x allen li
DOI: https://doi.org/10.1016/j.ijrobp.2013.06.1394
2013-01-01
Abstract:Quantitative definition of tumor volume based on positron emission tomography (PET) is affected by partial volume effect (PVE) that has been shown to result in underestimations of the standardized uptake value (SUV) thus to decreased metabolically-active tumor volume (MATV). The purpose of this study is to assess the impact of PVE correction on the SUV and the PET defined MATV in patients with lung cancer. A voxel-by-voxel PVE correction method utilizing a recovery coefficient (RC) approach is implemented for correction in the region of interest (ROI). The RC was calculated based on the measured lesion SUVmax, the measured background average SUV, the injected lesion activity, and the injected background activity, based on the PET data of the NEMA phantom with six spheres of different sizes filled with appropriate amount of FDG to achieve activity in all 6 spheres to background ratios of 8:1, 6:1, and 4:1 in three measurements. The PVE correction was applied to the FDG PET data acquired for representative patients with early-stage lung cancer. To reduce subjective uncertainties a circular (sphere in 3D) ROI was drawn to cover the tumor region on the fused PET/CT. For the background measurement, a duplicated ROI with the same diameter was drawn in a separate region inside the lung without any visible uptake. The tumor volume was delineated on the CT and on the PET using three different cutoff values: SUV of 2.5, SUV of 3.0, and 42% of SUVmax. The PVE-corrected SUVmax and MATV were compared with their uncorrected values For all patients studied, the mean RC was 0.72 (ranging 0.58-0.78) based on tumor diameter on the CT (ranging 1.6-2.7) cm and SUVmax in tumor to background ratio (ranging 5.5-16). The mean SUVmax values in the ROI were 6.37 (ranging 3.3-8.0) and 8.26 (ranging 5.26-9.88) g/mL, respectively, before and after PVE correction. Substantial differences were observed between the MATV before and after PVE correction, with a mean and range of 2.38 (0.82-5.75) cm3, 4.2 (1.13-8.53) cm3 using SUV of 2.5, and 1.47 (0.2-3.65) cm3, 2.39 (0.82-4.94) using SUV of 3.0, respectively. A slight difference was seen in the MATV defined by 42%SUVmax before and after PVE correction, with the mean and range 2.76 (0.44-4.94) cm3, and 2.32 (0.44-3.85) cm3, respectively. The difference between CT- and PET-defined maximum dimension of tumor volume sizes was reduced from 30% to 24% after the PVE correction. The partial volume effect correction on PET considerably impacts SUV and improves the SUV-defined metabolically active tumor volume for early-stage lung cancer patients, particularly with small tumor volumes.
What problem does this paper attempt to address?